Reconstructing the pulmonary niche with stem cells: a lung story.
Barbie VargheseZihan LingXi RenPublished in: Stem cell research & therapy (2022)
The global burden of pulmonary disease highlights an overwhelming need in improving our understanding of lung development, disease, and treatment. It also calls for further advances in our ability to engineer the pulmonary system at cellular and tissue levels. The discovery of human pluripotent stem cells (hPSCs) offsets the relative inaccessibility of human lungs for studying developmental programs and disease mechanisms, all the while offering a potential source of cells and tissue for regenerative interventions. This review offers a perspective on where the lung stem cell field stands in terms of accomplishing these ambitious goals. We will trace the known stages and pathways involved in in vivo lung development and how they inspire the directed differentiation of stem and progenitor cells in vitro. We will also recap the efforts made to date to recapitulate the lung stem cell niche in vitro via engineered cell-cell and cell-extracellular matrix (ECM) interactions.
Keyphrases
- stem cells
- cell therapy
- pluripotent stem cells
- extracellular matrix
- pulmonary hypertension
- single cell
- endothelial cells
- small molecule
- induced apoptosis
- high throughput
- risk factors
- cell proliferation
- risk assessment
- cell death
- signaling pathway
- induced pluripotent stem cells
- climate change
- endoplasmic reticulum stress
- human health
- heavy metals
- combination therapy
- cell cycle arrest
- tissue engineering